For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Harnessing the power of knockout validation for research reproducibility

Related

  • Knockout cell lines
    • Knockout cell lysates
      • Knockout cell line or lysate selection tool
        • Overcoming the perils of poor antibody specificity
          • Validating antibodies with KO technology webinar
            • Fast-track you research with KO cell lines
              • Generating cell knockouts with CRISPR-Cas9 technology
                • Custom CRISPR cell engineering services
                  • Custom cell lines: factors to consider
                    • CRISPR cell engineering to speed the drug pipeline
                      • Applying CRISPR assays to drug discovery

                        Join Dr Hanna Dreja, Abcam’s Principal Quality Control Scientist, as she discusses how knockout cell lines are being used to increase validation standards and support the reproducibility of research across the life science industry. 


                        Webinar objectives:

                        • Discover the benefits of working with knockout cell lines both as a technical validation tool and to unlock key biological questions
                        • Gain expert insight on how knockout cell lines are being applied from basic research and target discovery to pharmacogenomics
                        • See how Abcam are overcoming the common challenges of working with knockout cell lines


                        Some additional questions asked during the webinar are answered by our CRISPR experts below.
                        • Are flow cytometry and RNA detection sufficient to confirm CRISPR knockout of a cell surface protein?

                        CRISPR KO is performed by the insertion or deletion of nucleotides in the target gene sequence. This results in a frameshift in the gene sequence that prevents expression of the complete protein as the translational machinery will hit a premature stop codon. As a result, you end up with a tiny protein that will be degraded.

                        The resulting mRNA undergoes nonsense-mediated decay, as the cell detects that it is not fully translated. However, this process is not 100% efficient 1.

                        If you have confidence in your Abs, I would recommend using protein detection to determine if your protein is truly knocked out.

                        • How do antibodies work in confirming a CRISPR knockout?

                        To demonstrate that an antibody binds specifically to the protein of interest, one needs to use a negative control – a control sample that does NOT contain this protein. If you have a cell line that normally expresses the protein, and you genetically modify this to no longer express the protein, you have two perfectly matched samples: a positive and a negative control sample. If your antibody is specific, you will no longer detect the signal in the knockout sample.

                        Browse the KO catalog


                        About the presenter:

                        Hanna Dreja received a PhD from Imperial College (London) and completed postdoctoral research at several academic institutes (Institut de Génétique Moléculaire de Montpellier (France), Queen Mary’s University (London) and the University of Cambridge). She has developed a broad scientific skill base with a strong focus on antibodies and infectious agents. 

                        As a team leader of the Scientific Quality Control team at Abcam, her mission is to provide products that exceed our customers' high expectations - helping them to discover more, faster. The knockout initiative has been a cornerstone of the recent team successes and was recognized in the prestigious CiteAb award in 2016 and 2020. 


                        References

                        1. Smits AH et al. Biological plasticity rescues target activity in CRISPR knockout-outs. Nat Meth. 16, 1087–1093(2019)




                        Get resources and offers direct to your inbox Sign up
                        A-Z by research area
                        • Cancer
                        • Cardiovascular
                        • Cell biology
                        • Developmental biology
                        • Epigenetics & Nuclear signaling
                        • Immunology
                        • Metabolism
                        • Microbiology
                        • Neuroscience
                        • Signal transduction
                        • Stem cells
                        A-Z by product type
                        • Primary antibodies
                        • Secondary antibodies
                        • Biochemicals
                        • Isotype controls
                        • Flow cytometry multi-color selector
                        • Kits
                        • Loading controls
                        • Lysates
                        • Peptides
                        • Proteins
                        • Slides
                        • Tags and cell markers
                        • Tools & Reagents
                        Help & support
                        • Support
                        • Make an Inquiry
                        • Protocols & troubleshooting
                        • Placing an order
                        • RabMAb products
                        • Biochemical product FAQs
                        • Training
                        • Browse by Target
                        Company
                        • Corporate site
                        • Investor relations
                        • Company news
                        • Careers
                        • About us
                        • Blog
                        Events
                        • Tradeshows
                        • Conferences
                        International websites
                        • abcam.cn
                        • abcam.co.jp

                        Join with us

                        • LinkedIn
                        • facebook
                        • Twitter
                        • YouTube
                        • Terms of sale
                        • Website terms of use
                        • Cookie policy
                        • Privacy policy
                        • Legal
                        • Modern slavery statement
                        © 1998-2023 Abcam plc. All rights reserved.